Streetbeat News

Stock Prices

COIN

The article provides a detailed comparison of Coinbase Global Inc. (NASDAQ: COIN) with its competitors in the Capital Markets industry. It highlights Coinbase's high valuation ratios (P/E, P/B, P/S) and strong operational metrics (ROE, EBITDA, gross profit, revenue growth) relative to industry averages. The analysis suggests potential overvaluation but also underscores Coinbase's robust financial performance and growth prospects.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:00 pm

AN

AutoNation, Inc. (NYSE:AN) reported Q2 earnings that missed analyst expectations due to a cyber incident at CDK Global. Despite the miss, the company showed strong cash flow and capital allocation, including significant share repurchases. AN shares rose 6.78% following the report.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2024 | 3:00 pm

MRK

The article provides a comprehensive comparison of Merck & Co (NYSE:MRK) against its competitors in the Pharmaceuticals industry, focusing on key financial metrics, market position, and growth prospects. Merck shows potential undervaluation with low PE, PB, and PS ratios, and strong profitability with a high ROE. However, it faces challenges with lower EBITDA, gross profit, and revenue growth compared to industry averages.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:00 pm

COST

The article provides a comprehensive comparison of Costco Wholesale (NASDAQ:COST) against its key competitors in the Consumer Staples Distribution & Retail industry. It highlights Costco's high valuation ratios (P/E, P/B, P/S), strong ROE, and impressive revenue growth, while noting its lower EBITDA and gross profit compared to industry averages. Additionally, Costco's lower debt-to-equity ratio indicates a stronger financial position relative to its peers.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:00 pm

CSR

In the last three months, 4 analysts have published ratings on Center (NYSE:CSR), with a mix of bullish and neutral perspectives. The average 12-month price target has increased to $70.0, with a high estimate of $75.00 and a low estimate of $64.00. Analysts have recently raised their price targets, reflecting positive sentiment. Center, a REIT focusing on apartment communities, has shown modest revenue growth but faces challenges with profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:00 pm

OSTX

OS Therapies Incorporated (NYSE:OSTX) is set to IPO on August 1st on the NYSE, offering shares at $4.00 each. The insider lock-up period will last 180 days, ending on January 28, 2025. The company focuses on treatments for osteosarcoma and other solid tumors.

Portfolio Pulse from Benzinga Insights

July 31, 2024 | 3:00 pm

IWM

SPY

A recent poll indicates that nearly half of respondents want the Federal Reserve to cut rates immediately, while 30% prefer a rate cut in September. The July FOMC meeting is expected to maintain the current federal funds rate, but easing inflation has increased the likelihood of rate cuts in the near future. Small cap stocks, represented by the iShares Russell 2000 ETF (IWM), have outperformed the SPDR S&P 500 ETF Trust (SPY) recently, as investors anticipate potential rate cuts.

Portfolio Pulse from Chris Katje

July 31, 2024 | 2:57 pm

STRA

Strategic Education shares are trading lower following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:56 pm

ROCK

Gibraltar Industries shares are trading lower after the company reported worse-than-expected Q2 financial results and cut its FY24 net sales guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:56 pm

APLS

Traders are closely monitoring Apellis Pharmaceuticals after Jefferies circulated comments about an FDA FAERS update that included a new death related to Syfovre. Jefferies maintains that this does not change their view on Syfovre's safety.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 2:55 pm